Magnetic Resonance - Technology Information Portal Welcome to MRI Technology
Info
  Sheets

Out-
      side
 



 
 'Contrast Agents' 
SEARCH FOR    
 
  2 3 5 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Result : Searchterm 'Contrast Agents' found in 17 terms [] and 118 definitions []
1 - 5 (of 135)     next
Result Pages : [1 2 3 4]  [5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 ... ]
Searchterm 'Contrast Agents' was also found in the following services: 
spacer
News  (49)  Resources  (7)  Forum  (8)  
 
Contrast AgentsForum -
related threadsInfoSheet: - Contrast Agents - 
Intro, Overview, 
Characteristics, 
Types of, 
etc.MRI Resource Directory:
 - Contrast Agents -
 
Contrast agents are chemical substances introduced to the anatomical or functional region being imaged, to increase the differences between different tissues or between normal and abnormal tissue, by altering the relaxation times. MRI contrast agents are classified by the different changes in relaxation times after their injection.
Positive contrast agents cause a reduction in the T1 relaxation time (increased signal intensity on T1 weighted images). They (appearing bright on MRI) are typically small molecular weight compounds containing as their active element Gadolinium, Manganese, or Iron. All of these elements have unpaired electron spins in their outer shells and long relaxivities.
Some typical contrast agents as gadopentetate dimeglumine, gadoteridol, and gadoterate meglumine are utilized for the central nervous system and the complete body; mangafodipir trisodium is specially used for lesions of the liver and gadodiamide for the central nervous system.
Negative contrast agents (appearing predominantly dark on MRI) are small particulate aggregates often termed superparamagnetic iron oxide (SPIO). These agents produce predominantly spin spin relaxation effects (local field inhomogeneities), which results in shorter T1 and T2 relaxation times.
SPIO's and ultrasmall superparamagnetic iron oxides (USPIO) usually consist of a crystalline iron oxide core containing thousands of iron atoms and a shell of polymer, dextran, polyethyleneglycol, and produce very high T2 relaxivities. USPIOs smaller than 300 nm cause a substantial T1 relaxation. T2 weighted effects are predominant.
A special group of negative contrast agents (appearing dark on MRI) are perfluorocarbons (perfluorochemicals), because their presence excludes the hydrogen atoms responsible for the signal in MR imaging.

The design objectives for the next generation of MR contrast agents will likely focus on prolonging intravascular retention, improving tissue targeting, and accessing new contrast mechanisms. Macromolecular paramagnetic contrast agents are being tested worldwide. Preclinical data shows that these agents demonstrate great promise for improving the quality of MR angiography, and in quantificating capillary permeability and myocardial perfusion.
Ultrasmall superparamagnetic iron oxide (USPIO) particles have been evaluated in multicenter clinical trials for lymph node MR imaging and MR angiography, with the clinical impact under discussion. In addition, a wide variety of vector and carrier molecules, including antibodies, peptides, proteins, polysaccharides, liposomes, and cells have been developed to deliver magnetic labels to specific sites. Technical advances in MR imaging will further increase the efficacy and necessity of tissue-specific MRI contrast agents.

See also Adverse Reaction and Nephrogenic Systemic Fibrosis.

See also the related poll result: 'The development of contrast agents in MRI is'
 
Images, Movies, Sliders:
 Delayed Myocardial Contrast Enhancement from Infarct  Open this link in a new window
      

Courtesy of  Robert R. Edelman
 Left Circumflex Ischemia First-pass Contrast Enhancement  Open this link in a new window
 MR Colonography Gadolinium per Rectum  Open this link in a new window
      

Courtesy of  Robert R. Edelman
 CE MRA of the Aorta  Open this link in a new window
    
SlidersSliders Overview

 
Radiology-tip.comradContrast Agents,  Safety of Contrast Agents
spacer
Medical-Ultrasound-Imaging.comUltrasound Contrast Agents,  Ultrasound Contrast Agent Safety
spacer
 
• Share the entry 'Contrast Agents':  Facebook  Twitter  LinkedIn  
 
• Related Searches:
    • Gd Labeled Albumin
    • Blood Pool Agents
    • Contrast Enhanced Magnetic Resonance Angiography
    • Paramagnetism
    • Superparamagnetism
 
Further Reading:
  Basics:
Analysis of MRI contrast agents
Thursday, 17 November 2022   by www.sciencedaily.com    
New guidelines urge caution on use of contrast agents during MR scans
Tuesday, 8 August 2017   by www.dotmed.com    
New Study Sheds Light on Safety of Gadolinium-Based Contrast Agents
Wednesday, 29 November 2017   by www.empr.com    
A safer approach for diagnostic medical imaging
Monday, 29 September 2014   by www.eurekalert.org    
Manganese-based MRI contrast agents: past, present and future
Friday, 4 November 2011   by www.ncbi.nlm.nih.gov    
  News & More:
Brain imaging method may aid mild traumatic brain injury diagnosis
Tuesday, 16 January 2024   by parkinsonsnewstoday.com    
A Targeted Multi-Crystalline Manganese Oxide as a Tumor-Selective Nano-Sized MRI Contrast Agent for Early and Accurate Diagnosis of Tumors
Thursday, 18 January 2024   by www.dovepress.com    
FDA Approves Gadopiclenol for Contrast-Enhanced Magnetic Resonance Imaging
Tuesday, 27 September 2022   by www.pharmacytimes.com    
How to stop using gadolinium chelates for magnetic resonance imaging: clinical-translational experiences with ferumoxytol
Saturday, 5 February 2022   by www.ncbi.nlm.nih.gov    
Estimation of Contrast Agent Concentration in DCE-MRI Using 2 Flip Angles
Tuesday, 11 January 2022   by pubmed.ncbi.nlm.nih.gov    
Manganese enhanced MRI provides more accurate details of heart function after a heart attack
Tuesday, 11 May 2021   by www.news-medical.net    
Gadopiclenol: positive results for Phase III clinical trials
Monday, 29 March 2021   by www.pharmiweb.co    
Gadolinium-Based Contrast Agents Hypersensitivity: A Case Series
Friday, 4 December 2020   by www.dovepress.com    
Polysaccharide-Core Contrast Agent as Gadolinium Alternative for Vascular MR
Monday, 8 March 2021   by www.diagnosticimaging.com    
Water-based non-toxic MRI contrast agents
Monday, 11 May 2020   by chemistrycommunity.nature.com    
New method to detect early-stage cancer identified by Georgia State, Emory research team
Friday, 7 February 2020   by www.eurekalert.org    
Researchers Brighten Path for Creating New Type of MRI Contrast Agent
Friday, 7 February 2020   by www.newswise.com    
Manganese-based MRI contrast agent may be safer alternative to gadolinium-based agents
Wednesday, 15 November 2017   by www.eurekalert.org    
Sodium MRI May Show Biomarker for Migraine
Friday, 1 December 2017   by psychcentral.com    
A natural boost for MRI scans
Monday, 21 October 2013   by www.eurekalert.org    
For MRI, time is of the essence A new generation of contrast agents could make for faster and more accurate imaging
Tuesday, 28 June 2011   by scienceline.org    
Searchterm 'Contrast Agents' was also found in the following services: 
spacer
Radiology  (46) Open this link in a new windowUltrasound  (75) Open this link in a new window
Oral Contrast AgentsForum -
related threadsInfoSheet: - Contrast Agents - 
Intro, Overview, 
Characteristics, 
Types of, 
etc.MRI Resource Directory:
 - Contrast Agents -
 
A limitation of abdominal MRI can be the assessment of malignancies by difficulties to distinguish bowel from other organs or malignant masses. The use of oral contrast agents can reduce this problem. Properties of an ideal oral contrast agent are little or no absorption by the stomach or intestines, complete excretion, no motion or susceptibility artifacts, and uniform marking of the GI tract.
Gastrointestinal MRI contrast agents are divided in materials with bright appearance or dark appearance. The choice of a negative or a positive oral contrast agent depends on the specific problem or the pulse sequence.

See also Positive Oral Contrast Agents, Negative Oral Contrast Agents, Gastrointestinal Diamagnetic Contrast Agents, Gastrointestinal Paramagnetic Contrast Agents and Gastrointestinal Superparamagnetic Contrast Agents.

See also the related poll result: 'The development of contrast agents in MRI is'
spacer

• View the DATABASE results for 'Oral Contrast Agents' (17).Open this link in a new window

 
Further Reading:
  News & More:
Usefulness of MR Imaging for Diseases of the Small Intestine: Comparison with CT
2000   by www.ncbi.nlm.nih.gov    
Nottingham scientists exploit MRI technology to assist in the treatment of IBS
Thursday, 9 January 2014   by www.news-medical.net    
MRI Resources 
Services and Supplies - Health - Contrast Enhanced MRI - Musculoskeletal and Joint MRI - Shoulder MRI - Resources
 
Paramagnetic Contrast AgentsInfoSheet: - Contrast Agents - 
Intro, Overview, 
Characteristics, 
Types of, 
etc.MRI Resource Directory:
 - Contrast Agents -
 
Magnetic relaxation in tissues can be enhanced using contrast agents. The most commonly used for MRI are the paramagnetic contrast agents, which have their strongest effect on the T1, by increasing T1 signal intensity in tissues where they have accumulated.
MRI collects signal from the water protons, but the presence of these contrast agents enhances the relaxation of water protons in their vicinity. Paramagnetic contrast agents contain magnetic centers that create magnetic fields approximately one thousand times stronger than those corresponding to water protons. These magnetic centers interact with water protons in exactly the same way as the neighboring protons, but with much stronger magnetic fields, and therefore, have a much greater impact on relaxation rates, particularly on T1. In MRI, contrast agents are routinely injected intravenously to help identify areas of hypervascularity, as in malignant tumors.

See also Contrast Agents, Gadovist®, MultiHance®, Omniscan®, OptiMARK®.

See also the related poll result: 'The development of contrast agents in MRI is'
 
Images, Movies, Sliders:
 MRI Upper Abdomen T1 with Contrast  Open this link in a new window
    
 MRI Orbita T1  Open this link in a new window
 MRI Orbita T1 with Contrast  Open this link in a new window
    
 
spacer

• View the DATABASE results for 'Paramagnetic Contrast Agents' (22).Open this link in a new window


• View the NEWS results for 'Paramagnetic Contrast Agents' (1).Open this link in a new window.
 
Further Reading:
  Basics:
LEARNING CENTER FOR PARAMAGNETISM
2003   by www.naturesalternatives.com    
Contrast Agents: Safety Profile
   by www.clinical-mri.com    
Contrast Agents in Magnetic Resonance Imaging
1997
  News & More:
Gadolinium-containing contrast agents: removal of Omniscan and iv Magnevist, restrictions to the use of other linear agents
Friday, 5 January 2018   by www.gov.uk    
EMA's final opinion confirms restrictions on use of linear gadolinium agents in body scans
Friday, 21 July 2017   by www.ema.europa.eu    
FDA Drug Safety Communication: FDA warns that gadolinium-based contrast agents (GBCAs) are retained in the body; requires new class warnings
Tuesday, 19 December 2017   by www.fda.gov    
RSNA Statement on Gadolinium-Based MR Contrast Agents
Thursday, 1 February 2018   by www.rsna.org    
Contrast MRIs cause claims, concern, over residual metal in brain
Tuesday, 8 December 2015   by www.afr.com    
Searchterm 'Contrast Agents' was also found in the following services: 
spacer
News  (49)  Resources  (7)  Forum  (8)  
 
Ferromagnetic Contrast AgentsInfoSheet: - Contrast Agents - 
Intro, Overview, 
Characteristics, 
Types of, 
etc.MRI Resource Directory:
 - Contrast Agents -
 
A contrast agent, which due to their ferromagnetism produce local field inhomogeneities and hence visible image alterations in the tissues where they are present. Therefore, they can act as contrast media. Usually, particles exhibiting superparamagnetism rather than ferromagnetism are used.

See also the related poll result: 'The development of contrast agents in MRI is'
spacer
 
Further Reading:
  News & More:
SPL Medical starts clinical trial with contrast agent ferrotran
Tuesday, 11 February 2020   by www.radboudumc.nl    
SPL Medical receives approval for Clinical Trial with contrast agent Ferrotran® in 10 top radiology centers.
Friday, 15 March 2019   by ferrotran.com    
Searchterm 'Contrast Agents' was also found in the following services: 
spacer
Radiology  (46) Open this link in a new windowUltrasound  (75) Open this link in a new window
Hepatobiliary Contrast AgentsInfoSheet: - Contrast Agents - 
Intro, Overview, 
Characteristics, 
Types of, 
etc.MRI Resource Directory:
 - Contrast Agents -
 
The characteristics of a hepatobiliary contrast agent are specific liver uptake and excretion via the biliary system. The paramagnetic substance (e.g. manganese, gadolinium) is taken up by normal hepatocytes. Diseased liver tissue did not include hepatocytes or their function is disturbed. Therefore, the signal of healthy liver tissue increases on T1 weighted sequences, but not in the liver lesions.
Another type of liver imaging contrast agent is superparamagnetic iron oxide. These particles accumulate in the reticuloendothelial system (RES) of the liver, and darken the healthy liver tissue in T2 weighted images. RES cells (including Kupffer cells) are existing in healthy liver tissue, in altered tissue with reduced RES activity or without RES cells the contrast agent concentration is also low or not existing, which improves the liver to lesion contrast.
Benefits of hepatobiliary contrast agents:
Liver lesions (e.g., tumor, metastases, haemangioma etc.) are better detectable and to characterize.
These contrast agents are useful to analyze and evaluate the liver function (in cases of diffuse liver diseases e.g., cirrhosis).
Imaging of the gallbladder and biliary system is improved.

Differences of a hepatobiliary contrast agent compared with a targeted contrast agent for Kupffer cells:
The higher number of hepatocytes than Kupffer cells improves the uptake effectiveness of the contrast agent.
Hepatobiliary contrast agents enable a better opacification of the biliary ducts and the gallbladder caused by the biliary excretion.
Hepatobiliary contrast media are fast excreted agents. RES targeted contrast agents remain longer in the body, a fact that can increase possible side effects.

See also Superparamagnetic Contrast Agents, Hepatobiliary Chelates, Liver Imaging, Endoremâ„¢, Primovistâ„¢, and Classifications, Characteristics, etc.

See also the related poll result: 'The development of contrast agents in MRI is'
spacer

• View the DATABASE results for 'Hepatobiliary Contrast Agents' (11).Open this link in a new window

 
Further Reading:
  Basics:
Contrast MRI Best at Finding Liver Trouble - But Timing Matters
Sunday, 6 March 2011   by www.searchmedica.com    
  News & More:
Iron overload: accuracy of in-phase and out-of-phase MRI as a quick method to evaluate liver iron load in haematological malignancies and chronic liver disease
Friday, 1 June 2012   by www.ncbi.nlm.nih.gov    
EMA's final opinion confirms restrictions on use of linear gadolinium agents in body scans
Friday, 21 July 2017   by www.ema.europa.eu    
MAGNETIC RESONANCE IMAGING OF FOCAL LIVER LESIONS(.pdf)
2002
MRI Resources 
Nerve Stimulator - Raman Spectroscopy - Most Wanted - Pediatric and Fetal MRI - Spectroscopy pool - Image Quality
 
     1 - 5 (of 135)     next
Result Pages : [1 2 3 4]  [5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 ... ]
 Random Page
 
Share This Page
FacebookTwitterLinkedIn

MR-TIP    
Community   
User
Pass
Forgot your UserID/Password ?    



Next big thing in MRI will be :
AI 
remote operator 
personalized protocols 
helium-free 
molecular MRI 
portable MRI 

Look
      Ups





MR-TIP.com uses cookies! By browsing MR-TIP.com, you agree to our use of cookies.

Magnetic Resonance - Technology Information Portal
Member of SoftWays' Medical Imaging Group - MR-TIP • Radiology-TIP • Medical-Ultrasound-Imaging • 
Copyright © 2003 - 2024 SoftWays. All rights reserved. [ 28 March 2024]
Terms of Use | Privacy Policy | Advertising
 [last update: 2024-02-26 03:41:00]